We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+33.48%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$611M
AUM Growth
+$11.7M
Cap. Flow
-$91.9M
Cap. Flow %
-15.04%
Top 10 Hldgs %
4.77%
Holding
1,794
New
573
Increased
263
Reduced
313
Closed
643

Top Buys

Rank Stock Value
1
BBY icon
Best Buy
BBY
+$2.79M
2
BBWI icon
Bath & Body Works
BBWI
+$2.78M
3
AMD icon
Advanced Micro Devices
AMD
+$2.7M
4
NVDA icon
NVIDIA
NVDA
+$2.4M
5
XOM icon
ExxonMobil
XOM
+$2.28M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.42%
2 Technology 16.03%
3 Healthcare 14.17%
4 Industrials 13.91%
5 Financials 11.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMRS
1701
DELISTED
Amyris Inc.
AMRS
-37,035
Closed -$108K
KDNY
1702
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
-6,848
Closed -$83K
LSI
1703
DELISTED
Life Storage, Inc.
LSI
-7,890
Closed -$554K
NYMX
1704
DELISTED
Nymox Pharmaceutical Corp
NYMX
-18,912
Closed -$47K
DCP
1705
DELISTED
DCP Midstream, LP
DCP
-12,959
Closed -$145K
RUTH
1706
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
-39,690
Closed -$439K
ACOR
1707
DELISTED
Acorda Therapeutics
ACOR
-5,601
Closed -$346K
KBAL
1708
DELISTED
Kimball International
KBAL
-51,902
Closed -$547K
MNTV
1709
DELISTED
Momentive Global Inc. Common Stock
MNTV
-16,544
Closed -$366K
AQUA
1710
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
-41,136
Closed -$873K
SUMO
1711
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
-15,000
Closed -$327K
AGRX
1712
DELISTED
Agile Therapeutics
AGRX
-114
Closed -$693K
AIMC
1713
DELISTED
Altra Industrial Motion Corp
AIMC
-5,427
Closed -$201K
RUBY
1714
DELISTED
Rubius Therapeutics, Inc
RUBY
-10,872
Closed -$54K
OPNT
1715
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
-27,110
Closed -$203K
AVYA
1716
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
-15,814
Closed -$240K
REED
1717
DELISTED
Reeds, Inc. Common Stock
REED
-303
Closed -$14K
TCDA
1718
DELISTED
Tricida, Inc. Common Stock
TCDA
-13,450
Closed -$122K
PRTY
1719
DELISTED
Party City Holdco Inc.
PRTY
-274,930
Closed -$715K
DS
1720
DELISTED
Drive Shack Inc.
DS
-15,319
Closed -$17K
SWCH
1721
DELISTED
Switch, Inc. Class A Common Stock
SWCH
-19,006
Closed -$297K
TEN
1722
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
-85,053
Closed -$590K
QTNT
1723
DELISTED
Quotient Limited Ordinary Shares
QTNT
-296
Closed -$61K
DRE
1724
DELISTED
Duke Realty Corp.
DRE
-7,985
Closed -$295K
MNDT
1725
DELISTED
Mandiant, Inc. Common Stock
MNDT
-12,336
Closed -$152K

Similar funds

GSA Capital Partners's Q4 2020 Portfolio in Review

As of Q4 2020, GSA Capital Partners held 1,794 positions worth $611M, up 2% from $600M the previous quarter. Its ten largest holdings account for 4.8% of the portfolio.

GSA Capital Partners withdrew a net $91.9M in Q4 2020, closing 643 positions and reducing 313 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $10.9M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

Against the trend, GSA Capital Partners opened a new position in Best Buy worth $2.49M.

  • GSA Capital Partners's largest Q4 2020 buy was Best Buy: 24,945 shares worth $2.49M.
  • GSA Capital Partners added most to Advanced Micro Devices in Q4 2020, an estimated $2.7M increase.
  • GSA Capital Partners's biggest Q4 2020 reduction was BridgeBio Pharma, cutting an estimated $3.35M.
  • GSA Capital Partners fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2020, selling an estimated $10.9M.
  • GSA Capital Partners's ten largest holdings make up 4.8% of its $611M portfolio in Q4 2020.
  • GSA Capital Partners opened 573 new positions and closed 643 in Q4 2020.
  • GSA Capital Partners's portfolio value rose 2% quarter-over-quarter to $611M.

Based on GSA Capital Partners's 13F filing for Q4 2020, filed 3 Feb 2021.